tiprankstipranks
Trending News
More News >
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Contineum Therapeutics, Inc. Class A (CTNM) Similar Stocks

Compare
206 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Contineum Therapeutics, Inc. Class A
$11.63
$306.67M
-4.61
-17.11%
7 Buy
0 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$4.41
$41.17M
-0.25
-53.18%
3 Buy
4 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$26.02
$1.56B
96.23%
8 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$3.94
$329.48M
64.50%
2 Buy
0 Hold
0 Sell
Moderate Buy
Immuneering
$6.08
$471.36M
208.63%
6 Buy
0 Hold
0 Sell
Strong Buy
enGene Holdings
$8.46
$576.04M
28.38%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTNM
Contineum Therapeutics, Inc. Class A
11.63
-2.03
-14.86%
TVRD
Tvardi Therapeutics
4.41
-4.88
-52.53%
CAPR
Capricor Therapeutics
26.02
12.14
87.46%
DRTS
Alpha Tau Medical Ltd
5.05
1.95
62.90%
IMRX
Immuneering
6.08
4.35
251.45%
ENGN
enGene Holdings
8.46
2.16
34.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts